iifl-logo

Unichem Laboratories Ltd Quarterly Results

493.7
(-0.85%)
Aug 11, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Jun-2025Mar-2025Dec-2024Sept-2024Jun-2024

Gross Sales

526.6

587.18

533.09

507.36

483.34

Excise Duty

0

0

0

0

0

Net Sales

526.6

587.18

533.09

507.36

483.34

Other Operating Income

0

0

0

0

0

Other Income

6.82

9.25

13.62

8.69

3.76

Total Income

533.42

596.43

546.71

516.05

487.1

Total Expenditure

504.11

503.48

447.57

451.87

443.19

PBIDT

29.31

92.95

99.14

64.18

43.91

Interest

6.54

5.46

6.75

4.79

4.03

PBDT

22.77

87.49

92.39

59.39

39.88

Depreciation

31.79

29.69

30.54

32.26

32.07

Minority Interest Before NP

0

0

0

0

0

Tax

1.4

6.4

10.45

0.01

1.41

Deferred Tax

0.05

-1.57

-6.45

2.49

4.33

Reported Profit After Tax

-10.47

52.97

57.85

24.63

2.07

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-10.47

52.97

57.85

24.63

2.07

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-10.47

52.97

57.85

24.63

2.07

EPS (Unit Curr.)

-1.49

7.52

8.22

3.5

0.29

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

14.08

14.08

14.08

14.08

14.08

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

5.56

15.82

18.59

12.64

9.08

PBDTM(%)

4.32

14.9

17.33

11.7

8.25

PATM(%)

-1.98

9.02

10.85

4.85

0.42

Unichem Labs.: Related NEWS

Unichem Labs Q3 Profit Drops 20.5% YoY, Revenue Up 14.5%
6 Feb 2025|10:48 PM

Revenue increased by 14.5% to ₹533 crore from ₹466 crore the previous year.

Read More
Unichem Labs plans to consolidate US generic formulations bizz
23 Sep 2024|03:02 PM

Bayshore Pharmaceuticals is a 100% subsidiary of Unichem Laboratories' parent firm, Ipca Laboratories Ltd.

Read More
Unichem Labs Goa facility gets 5 observations from USFDA
16 Jul 2024|11:11 AM

According to the corporation, the observations have no influence on business continuity or supplies to the US market.

Read More
Top 10 stocks for today - 16th July, 2024
16 Jul 2024|08:47 AM

Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.